...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Any day now......

If Phase 3 will be listed at a later date, why does this mention 100 participants - which is the Phase 2 - and yet it shows March 22, 2022 for estimated primary completion date?

What about Don's "readout by August" statement?

 

https://clinicaltrials.gov/ct2/show/NCT04894266?spons=resverlogix&draw=2&rank=1

Estimated Study Start Date : June 12, 2021
Estimated Primary Completion Date : March 22, 2022
Estimated Study Completion Date : September 22, 2022

 

 
 
   
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants

 

Share
New Message
Please login to post a reply